학술논문

A Phase I/Phase II Study of (IV) Administered Tc 99m Tilmanocept (TCT) to Determine Safety, Optimal Clinical Dose Selection, and Imaging Timepoint in Patients Clinically Diagnosed with Rheumatoid Arhritis (RA)
Document Type
Journal
Source
JOURNAL OF NUCLEAR MEDICINE; MAY 1 2019, 60 2p. Supplement: 1
Subject
Language
English
ISSN
15355667